Literature DB >> 21069269

Variability in bladder volumes of full bladders in definitive radiotherapy for cases of localized prostate cancer.

Naoki Nakamura1, Naoto Shikama, Osamu Takahashi, Makiko Ito, Masatoshi Hashimoto, Masahiro Uematsu, Yukihiro Hama, Kenji Sekiguchi, Keiichi Nakagawa.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate variation in bladder volume of full bladders in definitive radiotherapy for localized prostate cancer and to investigate potential predictors of increased bladder volume variations. PATIENTS AND METHODS: In 40 patients, the bladder volume was measured with megavoltage computed tomography (MVCT) imaging performed just before irradiation during the administration of the 1st fraction (#1), the 10th fraction (#10), the 20th fraction (#20), and the 30th fraction (#30). Patients were instructed to avoid urinating for 60-90 minutes before the planning CT (pln-CT) scan and before daily irradiation. Patients were also encouraged to drink an unspecified volume of liquid that would result in a clear but tolerable urge to urinate.
RESULTS: The population-mean bladder volume (±1SD) was 219 ml (±83 ml) at the planning CT scan (pln-CT), 186 ml (±96 ml) at #1, 149 ml (±73 ml) at #10, 137 ml (±59 ml) at #20, and 136 ml (±60 ml) at #30. The mean intrapatient variation in bladder volume (1 SD relative to the mean bladder volume of each patient) was 38% (range: 10-84%). The bladder volume at the pln-CT was correlated with the intrapatient variance in bladder volume with a correlation coefficient of 0.54 and p <0.001.
CONCLUSION: We observed a significant decline in bladder volumes during the course of radiotherapy. The bladder volume at the pln-CT was a significant predictor of increased bladder volume variations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21069269     DOI: 10.1007/s00066-010-2105-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  23 in total

1.  Prostate position variability and dose-volume histograms in radiotherapy for prostate cancer with full and empty bladder.

Authors:  Michael Pinkawa; Branka Asadpour; Bernd Gagel; Marc D Piroth; Richard Holy; Michael J Eble
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-21       Impact factor: 7.038

2.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

3.  Magnetic resonance assessment of prostate localization variability in intensity-modulated radiotherapy for prostate cancer.

Authors:  Geert M Villeirs; Gert O De Meerleer; Koenraad L Verstraete; Wilfried J De Neve
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

4.  Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers.

Authors:  J Wu; T Haycocks; H Alasti; G Ottewell; N Middlemiss; M Abdolell; P Warde; A Toi; C Catton
Journal:  Radiother Oncol       Date:  2001-11       Impact factor: 6.280

5.  Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients.

Authors:  Tae Hyun Kim; Eui Kyu Chie; Dae Yong Kim; Sung Yong Park; Kwan Ho Cho; Kyung Hae Jung; Young Hoon Kim; Dae Kyung Sohn; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

6.  A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers.

Authors:  Alan M Nichol; Kristy K Brock; Gina A Lockwood; Douglas J Moseley; Tara Rosewall; Padraig R Warde; Charles N Catton; David A Jaffray
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-02       Impact factor: 7.038

7.  Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.

Authors:  Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Kerri Cote; Marian Loffredo; Delray Schultz; Ming-Hui Chen; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

8.  External-beam radiotherapy for clinically localized prostate cancer in Osaka, Japan, 1995-2006: time trends, outcome, and risk stratification.

Authors:  Yasuo Yoshioka; Osamu Suzuki; Kana Kobayashi; Teruki Teshima; Yuji Yamada; Tadayuki Kotsuma; Masahiko Koizumi; Kazufumi Kagawa; Masashi Chatani; Shigetoshi Shimamoto; Eiichi Tanaka; Hideya Yamazaki; Takehiro Inoue
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

9.  The variation of small bowel volume within the pelvis before and during adjuvant radiation for rectal cancer.

Authors:  J D Brierley; B J Cummings; C S Wong; M McLean; A Cashell; S Manter
Journal:  Radiother Oncol       Date:  1994-05       Impact factor: 6.280

10.  Variability of bladder filling in patients receiving radical radiotherapy to the prostate.

Authors:  Una M O'Doherty; Helen A McNair; Andrew R Norman; Elizabeth Miles; Simon Hooper; Mark Davies; Naomi Lincoln; Jan Balyckyi; Peter Childs; David P Dearnaley; Robert A Huddart
Journal:  Radiother Oncol       Date:  2006-06-16       Impact factor: 6.280

View more
  15 in total

1.  Assessment of accuracy and efficiency of atlas-based autosegmentation for prostate radiotherapy in a variety of clinical conditions.

Authors:  I Simmat; P Georg; D Georg; W Birkfellner; G Goldner; M Stock
Journal:  Strahlenther Onkol       Date:  2012-06-07       Impact factor: 3.621

2.  Moderate hypofractionation and simultaneous integrated boost by helical tomotherapy in prostate cancer: monoinstitutional report of acute tolerability assessment with different toxicity scales.

Authors:  Giuseppe Ferrera; Gianluca Mortellaro; Mariella Mannino; Giovanni Caminiti; Antonio Spera; Vanessa Figlia; Giuseppina Iacoviello; Gioacchino Di Paola; Rosario Mazzola; Antonio Lo Casto; Filippo Alongi; Maria Pia Pappalardo; Roberto Lagalla
Journal:  Radiol Med       Date:  2015-05-24       Impact factor: 3.469

3.  Patient positioning variations to reduce dose to normal tissues during 3D conformal radiotherapy for high-risk prostate cancer.

Authors:  K Czigner; P Agoston; G Forgács; M Kásler
Journal:  Strahlenther Onkol       Date:  2012-05-23       Impact factor: 3.621

4.  Physical and clinical implications of radiotherapy treatment of prostate cancer using a full bladder protocol.

Authors:  Raffaella Cambria; Barbara A Jereczek-Fossa; Dario Zerini; Federica Cattani; Flavia Serafini; Rosa Luraschi; Guido Pedroli; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2011-11-25       Impact factor: 3.621

5.  Prostate image-guided radiotherapy by megavolt cone-beam CT.

Authors:  Sergio Zucca; Barbara Carau; Ignazio Solla; Elisabetta Garibaldi; Paolo Farace; Giancarlo Lay; Gianfranco Meleddu; Pietro Gabriele
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

6.  The implementation of an empty bladder filling protocol for localised prostate volumetric modulated arctherapy (VMAT): early results of a single institution service evaluation.

Authors:  Gayan Chetiyawardana; Peter J Hoskin; Yat Man Tsang
Journal:  Br J Radiol       Date:  2020-07-31       Impact factor: 3.039

7.  Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT : Correlation between high-dose bladder volume, margin reduction, and genitourinary toxicity.

Authors:  Sonia Drozdz; Michael Schwedas; Henning Salz; Susan Foller; Thomas G Wendt
Journal:  Strahlenther Onkol       Date:  2016-01-07       Impact factor: 3.621

8.  Compliance with bladder protocol during concurrent chemoradiation for cancer of the cervix and its impact on enteritis: A prospective observational study.

Authors:  Sweta Bandanatham; Janaki Manur Gururajachar; Mohan Kumar Somashekar
Journal:  Rep Pract Oncol Radiother       Date:  2018-02-02

9.  Impact of bladder volume on acute genitourinary toxicity in intensity modulated radiotherapy for localized and locally advanced prostate cancer.

Authors:  Arne Grün; Michael Kawgan-Kagan; David Kaul; Harun Badakhshi; Carmen Stromberger; Volker Budach; Dirk Böhmer
Journal:  Strahlenther Onkol       Date:  2018-11-15       Impact factor: 3.621

10.  Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner.

Authors:  Jee Suk Chang; Hong In Yoon; Hye Jung Cha; Yoonsun Chung; Yeona Cho; Ki Chang Keum; Woong Sub Koom
Journal:  Radiat Oncol J       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.